Iridex CORP DEF 14A proxy statements

IRIDEX Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 12, 2026.

IRIDEX Corporation has issued a proxy supplement revising its proposed charter amendments, reducing the authorized common stock increase and retaining stockholder written consent rights, in response to an International Shareholder Services Inc. (ISS) recommendation and broader shareholder feedback.

IRIDEX Corporation received a notification from Nasdaq regarding non-compliance with the minimum stockholders' equity requirement for continued listing.

IRIDEX Corporation is seeking stockholder approval to amend and restate its charter to modernize it, increase authorized common stock, and revise terms related to its Series B Preferred Stock.

Iridex Corporation will hold its annual stockholder meeting on June 11, 2025, to vote on director elections, auditor ratification, share issuance approval, charter amendments, equity incentive plan changes, executive compensation, and meeting adjournment.

Iridex Corporation is holding its annual meeting on June 11, 2025, seeking stockholder approval for several proposals, including director elections, auditor ratification, stock issuance, charter amendments, and executive compensation.

Iridex Corporation's annual stockholder meeting will take place on June 18, 2024, to vote on director elections, ratification of the accounting firm, and executive compensation.

Iridex Corporation's proxy statement details proposals for the upcoming annual meeting, including director elections, auditor ratification, and executive compensation approval.